Flow Cytometry-based Method for Efficient Sorting of Senescent Cells
Erwan Goy,
Nathalie Martin,
Claire Drullion,
Laure Saas,
Olivier Molendi-Coste,
Laurent Pineau,
David Dombrowicz,
Emeric Deruy,
Hélène Bauderlique-Leroy,
Olivier Samyn,
Joe Nassour,
Yvan de Launoit,
Corinne Abbadie
Affiliations
Erwan Goy
Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277 – CANTHER – Cancer Heterogeneity, Plasticity and Resistance to Therapies, F-59000 Lille, France
Nathalie Martin
Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277 – CANTHER – Cancer Heterogeneity, Plasticity and Resistance to Therapies, F-59000 Lille, France
Claire Drullion
Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277 – CANTHER – Cancer Heterogeneity, Plasticity and Resistance to Therapies, F-59000 Lille, France
Laure Saas
Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277 – CANTHER – Cancer Heterogeneity, Plasticity and Resistance to Therapies, F-59000 Lille, France
Olivier Molendi-Coste
Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011- EGID, F-59000 Lille, France
Laurent Pineau
Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011- EGID, F-59000 Lille, France
David Dombrowicz
Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011- EGID, F-59000 Lille, France
Emeric Deruy
Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277 – CANTHER – Cancer Heterogeneity, Plasticity and Resistance to Therapies, F-59000 Lille, France
Hélène Bauderlique-Leroy
Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US41 – UAR 2014 – PLBS, F-59000 Lille, France
Olivier Samyn
Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277 – CANTHER – Cancer Heterogeneity, Plasticity and Resistance to Therapies, F-59000 Lille, France
Joe Nassour
Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277 – CANTHER – Cancer Heterogeneity, Plasticity and Resistance to Therapies, F-59000 Lille, France
Yvan de Launoit
Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277 – CANTHER – Cancer Heterogeneity, Plasticity and Resistance to Therapies, F-59000 Lille, France
Corinne Abbadie
Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277 – CANTHER – Cancer Heterogeneity, Plasticity and Resistance to Therapies, F-59000 Lille, France
Cellular senescence is a reprogrammed cell state triggered as an adaptative response to a variety of stresses, most often those affecting the genome integrity. Senescent cells accumulate in most tissues with age and contribute to the development of several pathologies. Studying molecular pathways involved in senescence induction and maintenance, or in senescence escape, can be hindered by the heterogeneity of senescent cell populations. Here, we describe a flow cytometry strategy for sorting senescent cells according to three senescence canonical markers whose thresholds can be independently adapted to be more or less stringent: (i) the senescence-associated-β-galactosidase (SA-β-Gal) activity, detected using 5-dodecanoylaminofluorescein Di-β-D-galactopyranoside (C12FDG), a fluorigenic substrate of β-galactosidase; (ii) cell size, proportional to the forward scatter value, since increased size is one of the major changes observed in senescent cells; and (iii) cell granularity, proportional to the side scatter value, which reflects the accumulation of aggregates, lysosomes, and altered mitochondria in senescent cells. We applied this protocol to the sorting of normal human fibroblasts at the replicative senescence plateau. We highlighted the challenge of sorting these senescent cells because of their large sizes, and established that it requires using sorters equipped with a nozzle of an unusually large diameter: at least 200 µm. We present evidence of the sorting efficiency and sorted cell viability, as well as of the senescent nature of the sorted cells, confirmed by the detection of other senescence markers, including the expression of the CKI p21 and the presence of 53BP1 DNA damage foci. Our protocol makes it possible, for the first time, to sort senescent cells from contaminating proliferating cells and, at the same time, to sort subpopulations of senescent cells featuring senescent markers to different extents.Graphical abstract